Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-04-30

Bioreductive release. Design and synthesis of novel indolequinone anticancer agents

Obiettivo



Research objectives and content
The purpose of the proposed research is to develop a focused program in the area of bioreductive anticancer agents by the design and synthesis of novel indolequinone based pro-drugs. A key aim is to exploit the combination of hypoxia and the presence of reductases in tumours to deliver specif1c agents (e.g enzyme inhibitors) which target processes important for tumour growth. The essence of the proposal, the molecular basis of which has already been demonstrated in key preliminary experiments. is to |design a reductively activated indolequinone, which can specifically deliver, selectively, inhibitors of processes important in tumour development. Thus it is proposed to prepare and fully evaluate a number of novel indolequinones, incorporating agents to target specific enzymes and growth factor receptors. The indolequinones that have been designed to study incorporate potent inhibitors of tyrosine kinases, nitric oxide synthase and tubulin assembly, that are linked to the bioreductively activated pro-drug by a metabolically stable covalent bond, thereby ensuring that the drug is released only under bioreductive conditions in hypoxic regions of tumours.
Training content (objective, benefit and expected impact)
The proposed project will provide a thorough grounding in the chemistry of heterocyclic compounds based on the indole ring system. Indole rings occur widely in Nature and are often incorporated into a range of biologically active compounds, and hence their study is a subject of immense importance. The host laboratory is one of the world's leaders in indole chemistry, and will be able to provide a wealth of expertise from which the applicant can benefit. The proposed research on novel antitumour compounds will make a major impact in the chemotherapy of cancer, since it relies on mechanisms which are specific to tumour cells.
Links With industry / industrial relevance (22)
The synthesis of new chemotherapeutic agents is a subject of immense importance given the biological activity of, and commercial interest in, such compounds. The host laboratory has established links with industries, notably in the pharmaceutical sector, with relevant interests. In particular, GlaxoWellcome, with research centres both in the UK and Italy, have taken an active interest in our work, and links have been established for future applications of our research.

Campo scientifico (EuroSciVoc)

CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP. Cfr.: Il Vocabolario Scientifico Europeo.

È necessario effettuare l’accesso o registrarsi per utilizzare questa funzione

Programma(i)

Programmi di finanziamento pluriennali che definiscono le priorità dell’UE in materia di ricerca e innovazione.

Argomento(i)

Gli inviti a presentare proposte sono suddivisi per argomenti. Un argomento definisce un’area o un tema specifico per il quale i candidati possono presentare proposte. La descrizione di un argomento comprende il suo ambito specifico e l’impatto previsto del progetto finanziato.

Invito a presentare proposte

Procedura per invitare i candidati a presentare proposte di progetti, con l’obiettivo di ricevere finanziamenti dall’UE.

Dati non disponibili

Meccanismo di finanziamento

Meccanismo di finanziamento (o «Tipo di azione») all’interno di un programma con caratteristiche comuni. Specifica: l’ambito di ciò che viene finanziato; il tasso di rimborso; i criteri di valutazione specifici per qualificarsi per il finanziamento; l’uso di forme semplificate di costi come gli importi forfettari.

RGI - Research grants (individual fellowships)

Coordinatore

UNIVERSITY OF EXETER
Contributo UE
Nessun dato
Indirizzo
STOCKER ROAD
EX4 4QD EXETER
Regno Unito

Mostra sulla mappa

Costo totale

I costi totali sostenuti dall’organizzazione per partecipare al progetto, compresi i costi diretti e indiretti. Questo importo è un sottoinsieme del bilancio complessivo del progetto.

Nessun dato

Partecipanti (1)

Il mio fascicolo 0 0